These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 9543159

  • 1. Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation.
    Yon L, Breault L, Contesse V, Bellancourt G, Delarue C, Fournier A, Lehoux JG, Vaudry H, Gallo-Payet N.
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1299-305. PubMed ID: 9543159
    [Abstract] [Full Text] [Related]

  • 2. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML, Modesti A, Palumbo C, Ulisse S, Fabbri A, Piccione E, Frajese G, Moretti C.
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [Abstract] [Full Text] [Related]

  • 3. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG.
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [Abstract] [Full Text] [Related]

  • 4. Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells.
    Basille M, Gonzalez BJ, Leroux P, Jeandel L, Fournier A, Vaudry H.
    Neuroscience; 1993 Nov; 57(2):329-38. PubMed ID: 8115042
    [Abstract] [Full Text] [Related]

  • 5. Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland.
    Yon L, Chartrel N, Feuilloley M, De Marchis S, Fournier A, De Rijk E, Pelletier G, Roubos E, Vaudry H.
    Endocrinology; 1994 Dec; 135(6):2749-58. PubMed ID: 7988467
    [Abstract] [Full Text] [Related]

  • 6. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO, Leung MY, Shea WL, Tse LY, Chang JP, Chow BK.
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [Abstract] [Full Text] [Related]

  • 7. Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells.
    Cavallaro S, D'Agata V, Guardabasso V, Travali S, Stivala F, Canonico PL.
    Mol Pharmacol; 1995 Jul; 48(1):56-62. PubMed ID: 7623775
    [Abstract] [Full Text] [Related]

  • 8. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
    Suda K, Smith DM, Ghatei MA, Murphy JK, Bloom SR.
    J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
    [Abstract] [Full Text] [Related]

  • 9. Expression of pituitary adenylate cyclase activating peptide (PACAP) and PACAP type I receptors in the rat adrenal medulla.
    Moller K, Sundler F.
    Regul Pept; 1996 Jul 05; 63(2-3):129-39. PubMed ID: 8837221
    [Abstract] [Full Text] [Related]

  • 10. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions.
    Shivers BD, Görcs TJ, Gottschall PE, Arimura A.
    Endocrinology; 1991 Jun 05; 128(6):3055-65. PubMed ID: 2036976
    [Abstract] [Full Text] [Related]

  • 11. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul 05; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 12. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1996 Dec 05; 50(6):1596-604. PubMed ID: 8967982
    [Abstract] [Full Text] [Related]

  • 13. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S, Prisco M, Sciarrillo R, De Falco M, Capaldo A, Gay F, Andreuccetti P, Laforgia V, Varano L.
    J Endocrinol; 2008 Feb 05; 196(2):291-303. PubMed ID: 18252952
    [Abstract] [Full Text] [Related]

  • 14. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
    Guijarro LG, Rodriguez-Henche N, García-López E, Noguerales F, Dapena MA, Juarranz MG, Prieto JC.
    J Clin Endocrinol Metab; 1995 Aug 05; 80(8):2451-7. PubMed ID: 7629241
    [Abstract] [Full Text] [Related]

  • 15. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells.
    Bodart V, Babinski K, Ong H, De Léan A.
    Endocrinology; 1997 Feb 05; 138(2):566-73. PubMed ID: 9002987
    [Abstract] [Full Text] [Related]

  • 16. Pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland.
    Yon L, Breault L, Contesse V, Bellancourt G, Delarue C, Fournier A, Lehoux JG, Gallo-Payet N, Vaudry H.
    Ann N Y Acad Sci; 1998 Dec 11; 865():416-9. PubMed ID: 9928041
    [No Abstract] [Full Text] [Related]

  • 17. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F, Puech R, Bockaert J, Brabet P, Bertrand G.
    Endocrinology; 2002 Apr 11; 143(4):1253-9. PubMed ID: 11897681
    [Abstract] [Full Text] [Related]

  • 18. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE, Tatsuno I, Miyata A, Arimura A.
    Endocrinology; 1990 Jul 11; 127(1):272-7. PubMed ID: 2361473
    [Abstract] [Full Text] [Related]

  • 19. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
    Margiotta JF, Pardi D.
    Mol Pharmacol; 1995 Jul 11; 48(1):63-71. PubMed ID: 7623776
    [Abstract] [Full Text] [Related]

  • 20. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M, Vaudry D, Coulouarn Y, Jegou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez B.
    J Comp Neurol; 2000 Oct 02; 425(4):495-509. PubMed ID: 10975876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.